162 related articles for article (PubMed ID: 24320494)
1. Improving spot-scanning proton therapy patient specific quality assurance with HPlusQA, a second-check dose calculation engine.
Mackin D; Li Y; Taylor MB; Kerr M; Holmes C; Sahoo N; Poenisch F; Li H; Lii J; Amos R; Wu R; Suzuki K; Gillin MT; Zhu XR; Zhang X
Med Phys; 2013 Dec; 40(12):121708. PubMed ID: 24320494
[TBL] [Abstract][Full Text] [Related]
2. Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose.
Zhu XR; Poenisch F; Song X; Johnson JL; Ciangaru G; Taylor MB; Lii M; Martin C; Arjomandy B; Lee AK; Choi S; Nguyen QN; Gillin MT; Sahoo N
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):552-9. PubMed ID: 21300457
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the accuracy of 3DVH software estimates of dose to virtual ion chamber and film in composite IMRT QA.
Olch AJ
Med Phys; 2012 Jan; 39(1):81-6. PubMed ID: 22225277
[TBL] [Abstract][Full Text] [Related]
4. Transitioning from measurement-based to combined patient-specific quality assurance for intensity-modulated proton therapy.
Chen M; Yepes P; Hojo Y; Poenisch F; Li Y; Chen J; Xu C; He X; Gunn GB; Frank SJ; Sahoo N; Li H; Zhu XR; Zhang X
Br J Radiol; 2020 Mar; 93(1107):20190669. PubMed ID: 31799859
[TBL] [Abstract][Full Text] [Related]
5. Automated Monte-Carlo re-calculation of proton therapy plans using Geant4/Gate: implementation and comparison to plan-specific quality assurance measurements.
Aitkenhead AH; Sitch P; Richardson JC; Winterhalter C; Patel I; Mackay RI
Br J Radiol; 2020 Oct; 93(1114):20200228. PubMed ID: 32726141
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of the accuracy of dose calculation using pencil beam and Monte Carlo algorithms and requirements for clinical quality assurance.
Ali I; Ahmad S
Med Dosim; 2013; 38(3):255-61. PubMed ID: 23558145
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy.
Johnson JE; Beltran C; Wan Chan Tseung H; Mundy DW; Kruse JJ; Whitaker TJ; Herman MG; Furutani KM
PLoS One; 2019; 14(2):e0212412. PubMed ID: 30763390
[TBL] [Abstract][Full Text] [Related]
8. Validation of a modern second-check dosimetry system using a novel verification phantom.
McDonald DG; Jacqmin DJ; Mart CJ; Koch NC; Peng JL; Ashenafi MS; Fugal MA; Vanek KN
J Appl Clin Med Phys; 2017 Jan; 18(1):170-177. PubMed ID: 28291938
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the influence of double and triple Gaussian proton kernel models on accuracy of dose calculations for spot scanning technique.
Hirayama S; Takayanagi T; Fujii Y; Fujimoto R; Fujitaka S; Umezawa M; Nagamine Y; Hosaka M; Yasui K; Omachi C; Toshito T
Med Phys; 2016 Mar; 43(3):1437-50. PubMed ID: 26936728
[TBL] [Abstract][Full Text] [Related]
10. A patient-specific aperture system with an energy absorber for spot scanning proton beams: Verification for clinical application.
Yasui K; Toshito T; Omachi C; Kibe Y; Hayashi K; Shibata H; Tanaka K; Nikawa E; Asai K; Shimomura A; Kinou H; Isoyama S; Fujii Y; Takayanagi T; Hirayama S; Nagamine Y; Shibamoto Y; Komori M; Mizoe JE
Med Phys; 2015 Dec; 42(12):6999-7010. PubMed ID: 26632055
[TBL] [Abstract][Full Text] [Related]
11. Validation of OSLD and a treatment planning system for surface dose determination in IMRT treatments.
Zhuang AH; Olch AJ
Med Phys; 2014 Aug; 41(8):081720. PubMed ID: 25086530
[TBL] [Abstract][Full Text] [Related]
12. IMRT quality assurance using a second treatment planning system.
Anjum MN; Parker W; Ruo R; Aldahlawi I; Afzal M
Med Dosim; 2010; 35(4):274-9. PubMed ID: 19944590
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric validation of a GPU-based dose engine for a fast in silico patient-specific quality assurance program in light ion beam therapy.
Magro G; Fassi M; Mirandola A; Rossi E; Molinelli S; Russo S; Bazani A; Vai A; Ciocca M; Donetti M; Mairani A
Med Phys; 2022 Dec; 49(12):7802-7814. PubMed ID: 36196033
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional gamma criterion for patient-specific quality assurance of spot scanning proton beams.
Chang C; Poole KL; Teran AV; Luckman S; Mah D
J Appl Clin Med Phys; 2015 Sep; 16(5):381–388. PubMed ID: 26699329
[TBL] [Abstract][Full Text] [Related]
15. Technical Note: Validation of halo modeling for proton pencil beam spot scanning using a quality assurance test pattern.
Lin L; Huang S; Kang M; Solberg TD; McDonough JE; Ainsley CG
Med Phys; 2015 Sep; 42(9):5138-43. PubMed ID: 26328965
[TBL] [Abstract][Full Text] [Related]
16. Platform for automatic patient quality assurance via Monte Carlo simulations in proton therapy.
Guterres Marmitt G; Pin A; Ng Wei Siang K; Janssens G; Souris K; Cohilis M; Langendijk JA; Both S; Knopf A; Meijers A
Phys Med; 2020 Feb; 70():49-57. PubMed ID: 31968277
[TBL] [Abstract][Full Text] [Related]
17. Modelling lateral beam quality variations in pencil kernel based photon dose calculations.
Nyholm T; Olofsson J; Ahnesjö A; Karlsson M
Phys Med Biol; 2006 Aug; 51(16):4111-8. PubMed ID: 16885628
[TBL] [Abstract][Full Text] [Related]
18. An algorithm to assess the need for clinical Monte Carlo dose calculation for small proton therapy fields based on quantification of tissue heterogeneity.
Bueno M; Paganetti H; Duch MA; Schuemann J
Med Phys; 2013 Aug; 40(8):081704. PubMed ID: 23927301
[TBL] [Abstract][Full Text] [Related]
19. Effects of minimum monitor unit threshold on spot scanning proton plan quality.
Howard M; Beltran C; Mayo CS; Herman MG
Med Phys; 2014 Sep; 41(9):091703. PubMed ID: 25186378
[TBL] [Abstract][Full Text] [Related]
20. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
